Regulatory Aspects concerning PA contamination in medicinal plants
DOI:
https://doi.org/10.5073/JfK.2020.04.04Keywords:
pyrrolozidine alkaloids, herbal medicinal products, contamination, limits, HMPCAbstract
The first reports on the occurrence of PA contamination in herbal teas were published in 2013, followed shortly afterwards by reports on the contamination of herbal medicinal products with PA. As a result, various national regulatory authorities and the Committee for Herbal Medicinal Products of the European Medicines Agency requested marketing authorisation holders of herbal medicinal products in Europe to carry out risk assessments and risk reduction measures with regard to pyrrolizidine alkaloids. Both, national authorities and the HMPC introduced limits for PA as a contaminant. In addition, the HMPC had endorsed the European Pharmacopoeia to develop a suitable PA determination method in the field of trace analysis. This is currently available as a draft for public consultation.
Downloads
Published
Issue
Section
License
The content of the journal is licensed under the Creative Commons Attribution 4.0 License. Any user is free to share and adapt (remix, transform, build upon) the content as long as the original publication is attributed (authors, title, year, journal, issue, pages).
The copyright of the published work remains with the authors. The authors grant the Journal of Cultivated Plants, the Julius Kühn-Institut and the OpenAgrar repository the non-exclusive right to distribute and exploit the work.